These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1762129)

  • 1. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Summary and conclusions.
    Abrahamson S
    J Radiat Res; 1991 Mar; 32 Suppl():395-412. PubMed ID: 1762129
    [No Abstract]   [Full Text] [Related]  

  • 2. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Theoretical background of the Dosimetry System 86 (D586).
    Kosako T
    J Radiat Res; 1991 Mar; 32 Suppl():11-9. PubMed ID: 1762097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors.
    J Radiat Res; 1991 Mar; 32 Suppl():1-412. PubMed ID: 1762094
    [No Abstract]   [Full Text] [Related]  

  • 4. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Future perspective of radiobiological studies.
    Akiyama M; Nakamura N
    J Radiat Res; 1991 Mar; 32 Suppl():394. PubMed ID: 1762128
    [No Abstract]   [Full Text] [Related]  

  • 5. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. The Dosimetry System 1986 (DS86) and the Tentative Dosimetry System 1965 (T65D): how do they compare, what is left to do?
    Thiessen JW; Kaul DC
    J Radiat Res; 1991 Mar; 32 Suppl():1-10. PubMed ID: 1762093
    [No Abstract]   [Full Text] [Related]  

  • 6. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Current summary of lymphocyte survival study.
    Nakamura N; Akiyama M; Kyoizumi S; Kusunoki Y
    J Radiat Res; 1991 Mar; 32 Suppl():327-9. PubMed ID: 1762122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Future research in epidemiology and statistics at RERF.
    Mabuchi K; Preston DL
    J Radiat Res; 1991 Mar; 32 Suppl():375-7. PubMed ID: 1762125
    [No Abstract]   [Full Text] [Related]  

  • 8. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Hyperparathyroidism.
    Fujiwara S
    J Radiat Res; 1991 Mar; 32 Suppl():245-8. PubMed ID: 1762112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Residual radioactivity in neutron-exposed objects and residual alpha radioactivity in black rain areas.
    Sakanoue M; Komura K; Tan K
    J Radiat Res; 1991 Mar; 32 Suppl():58-68. PubMed ID: 1762132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Tumor registries and cancer incidence studies.
    Mabuchi K; Soda M
    J Radiat Res; 1991 Mar; 32 Suppl():239-44. PubMed ID: 1762111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki, Japan.
    FOLLEY JH; BORGES W; YAMAWAKI T
    Am J Med; 1952 Sep; 13(3):311-21. PubMed ID: 12985588
    [No Abstract]   [Full Text] [Related]  

  • 12. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Radiation cataract.
    Otake M; Schull WJ
    J Radiat Res; 1991 Mar; 32 Suppl():283-93. PubMed ID: 1762117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Thyroid cancer: reports up to date and a review.
    Takeichi N; Ezaki H; Dohi K
    J Radiat Res; 1991 Mar; 32 Suppl():180-8. PubMed ID: 1762104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Workshop Report on Atomic Bomb Dosimetry--Review of Dose Related Factors for the Evaluation of Exposures to Residual Radiation at Hiroshima and Nagasaki.
    Kerr GD; Egbert SD; Al-Nabulsi I; Bailiff IK; Beck HL; Belukha IG; Cockayne JE; Cullings HM; Eckerman KF; Granovskaya E; Grant EJ; Hoshi M; Kaul DC; Kryuchkov V; Mannis D; Ohtaki M; Otani K; Shinkarev S; Simon SL; Spriggs GD; Stepanenko VF; Stricklin D; Weiss JF; Weitz RL; Woda C; Worthington PR; Yamamoto K; Young RW
    Health Phys; 2015 Dec; 109(6):582-600. PubMed ID: 26509626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Biochemical genetics study.
    Satoh C
    J Radiat Res; 1991 Mar; 32 Suppl():378-84. PubMed ID: 1762126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term epidemiological studies of atomic bomb survivors in Hiroshima and Nagasaki: study populations, dosimetry and summary of health effects.
    Okubo T
    Radiat Prot Dosimetry; 2012 Oct; 151(4):671-3. PubMed ID: 22908354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Chromosome abnormality in early entrants.
    Kamada N
    J Radiat Res; 1991 Mar; 32 Suppl():275-7. PubMed ID: 1762115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy among atomic bomb survivors, Hiroshima and Nagasaki.
    Kato K; Antoku S; Russell WJ; Fujita S; Pinkston JA; Hayabuchi N; Hoshi M; Kodama K
    Radiat Res; 1998 Jun; 149(6):614-24. PubMed ID: 9611100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies.
    Mabuchi K; Soda M; Ron E; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Preston DL; Thompson DE
    Radiat Res; 1994 Feb; 137(2 Suppl):S1-16. PubMed ID: 8127951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of thirty years study of Hiroshima and Nagasaki atomic bomb survivors. II. Biological effects. H. Cataracts.
    Dodo T
    J Radiat Res; 1975 Sep; 16 Suppl():132-7. PubMed ID: 1195196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.